Package 43485-104-60

{"route": ["ORAL"], "spl_id": "890ef534-7363-4f2b-b125-8f62e2eb26d0", "openfda": {"nui": ["N0000008486"], "unii": ["44YRR34555"], "rxcui": ["1736037", "1736044", "1736045", "1736047", "1736048", "1736050", "1736051", "1736053"], "spl_set_id": ["be651c31-383f-11e4-916c-0800200c9a66"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "manufacturer_name": ["Aprecia Pharmaceuticals, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "60 BLISTER PACK in 1 CARTON (43485-104-60)  / 1 TABLET, FOR SUSPENSION in 1 BLISTER PACK (43485-104-01)", "package_ndc": "43485-104-60", "marketing_end_date": "20280630", "marketing_start_date": "20160205"}], "brand_name": "Spritam", "product_id": "43485-104_890ef534-7363-4f2b-b125-8f62e2eb26d0", "dosage_form": "TABLET, FOR SUSPENSION", "pharm_class": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "43485-104", "generic_name": "levetiracetam", "labeler_name": "Aprecia Pharmaceuticals, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Spritam", "active_ingredients": [{"name": "LEVETIRACETAM", "strength": "1000 mg/1"}], "application_number": "NDA207958", "marketing_category": "NDA", "marketing_end_date": "20280630", "marketing_start_date": "20160205"}